Literature DB >> 21909744

[Chronic migraine and headache by medication overuse. Evolution and revision of classification].

H Göbel1, A Heinze.   

Abstract

The first International classification of headache disorders (ICHD-I) described migraine as a recurring headache disorder manifesting in attacks lasting 4-72 h. The headache frequency was not considered in these first diagnostic criteria of migraine. Thus, a chronic migraine with at least 15 migraine days per month was only included in the ICHD-II in 2004. Meanwhile, the diagnosis of chronic daily headache and transformed migraine had been established in the USA. The term transformed migraine describes the transformation of an episodic migraine into a chronic one, whether medication overuse had been present or not. Up till now a widely accepted definition of chronic migraine and medication overuse headache has not been established due to different views. An overview of the evolution of the diagnostic criteria for both headache disorders in recent years is provided.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909744     DOI: 10.1007/s00482-011-1085-5

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  10 in total

1.  The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

Authors:  S D Silberstein; J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; T J Steiner
Journal:  Cephalalgia       Date:  2005-06       Impact factor: 6.292

2.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

3.  OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Authors:  David W Dodick; Catherine C Turkel; Ronald E DeGryse; Sheena K Aurora; Stephen D Silberstein; Richard B Lipton; Hans-Christoph Diener; Mitchell F Brin
Journal:  Headache       Date:  2010-05-07       Impact factor: 5.887

4.  The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.

Authors:  Marcelo E Bigal; Alan M Rapoport; Stewart J Tepper; Fred D Sheftell; Richard B Lipton
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

Review 5.  Chronic daily headache.

Authors:  Stephen D Silberstein
Journal:  J Am Osteopath Assoc       Date:  2005-04

6.  Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.

Authors:  C F Dobson; Y Tohyama; M Diksic; E Hamel
Journal:  Cephalalgia       Date:  2004-01       Impact factor: 6.292

7.  Classification of daily and near-daily headaches: field trial of revised IHS criteria.

Authors:  S D Silberstein; R B Lipton; M Sliwinski
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

8.  Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

Authors:  F Sorge; R De Simone; E Marano; M Nolano; G Orefice; P Carrieri
Journal:  Cephalalgia       Date:  1988-03       Impact factor: 6.292

Review 9.  Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse.

Authors:  H-C Diener; D W Dodick; P J Goadsby; M E Bigal; G Bussone; S D Silberstein; N Mathew; S Ascher; J Morein; J F Hulihan; D M Biondi; S J Greenberg
Journal:  Cephalalgia       Date:  2009-04-23       Impact factor: 6.292

10.  Field testing alternative criteria for chronic migraine.

Authors:  M E Bigal; S J Tepper; F D Sheftell; A M Rapoport; R B Lipton
Journal:  Cephalalgia       Date:  2006-04       Impact factor: 6.292

  10 in total
  1 in total

1.  [Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society].

Authors:  A Straube; C Gaul; S Förderreuther; P Kropp; M Marziniak; S Evers; W H Jost; H Göbel; C Lampl; P S Sándor; A R Gantenbein; H-C Diener
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.